FindMyKOL
Clinical trialNCT05317403RecruitingPhase 1Interventional

Venetoclax to Augment Epigenetic Modification and Chemotherapy

SponsorMedical College of WisconsinEnrollment40Acute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, in Relapse
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The investigator is testing the addition of venetoclax to 5-azacitidine and vorinostat followed by standard chemotherapy to enhance treatment response in AML patients.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Children'S Wisconsin

    Milwaukee, Wisconsin, United States

    Michael Burke, MDZachary T. Graff, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AzacitadineCytarabine →Filgrastim →Fludarabine →Venetoclax →Vorinostat →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2023
Primary completion
31 Jan 2027
Completion
31 Jan 2027
Last update posted
12 Jan 2026
Registered enrollment
40
Registry id
NCT05317403
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.